Moreover, we observed that CD204 did not co-localize with immunosuppressive molecules, such as IL-10, B7-H1, or B7-H4, in UCB tissues (data not shown), which suggested that the expression of CD204 on Mφs is sufficient to promote tumor progression independently of other pathways. The gene discussed is VTCN1; the disease is neoplasm.